Krystal Biotech (KRYS) Interest Expenses (2021)

Krystal Biotech has disclosed Interest Expenses across 1 years of filings, most recently posting $1.5 million for Q1 2021.

• In Q1 2021, Interest Expenses changed N/A year-over-year to $1.5 million; the TTM figure through Dec 2021 stood at $1.5 million (changed N/A YoY), while the FY2021 annual figure was $1.5 million, changed N/A from the prior year.
• Interest Expenses came in at $1.5 million for Q1 2021 at Krystal Biotech.
• In the past five years, Interest Expenses ranged from a high of $1.5 million in Q1 2021 to a low of $1.5 million in Q1 2021.